4.2 Article

Estrogen Receptor-beta, Estrogen Receptor-alpha, and Progesterone Resistance in Endometriosis

期刊

SEMINARS IN REPRODUCTIVE MEDICINE
卷 28, 期 1, 页码 36-43

出版社

THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0029-1242991

关键词

ER-beta; ER-alpha; PR; progesterone resistance; DNA methylation; epigenetic; promoter; gene regulation; transcription

资金

  1. NICHD [HD040093]
  2. Friends of Prentice
  3. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD040093, R01HD044715] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Loss of progesterone signaling in the endometrium may be a causal factor in the development of endometriosis, and progesterone resistance is commonly observed in women with this disease. In endometriotic stromal cells, the levels of progesterone receptor (PR), particularly the PR-B isoform, are significantly decreased, leading to a loss of paracrine signaling. PR deficiency likely underlies the development of progesterone resistance in women with endometriosis who no longer respond to progestin therapy. Here we review the complex epigenetic and transcriptional mechanisms leading to PR deficiency. The initial event may involve deficient methylation of the estrogen receptor (ER)beta promoter resulting in pathologic overexpression of ER beta in endometriotic stromal cells. We speculate that alterations in the relative levels of ER beta and ER alpha in endometrial tissue dictate E2-regulated PR expression, such that a decreased ER alpha-ER beta ratio may result in suppression of PR. In this review, we propose a molecular model that may be responsible for changes in ER beta and ER alpha leading to PR loss and progesterone resistance in endometriosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Genetics & Heredity

Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma

Xiuhua Xu, J. Julie Kim, Yinuo Li, Jia Xie, Changshun Shao, Jian-Jun Wei

JOURNAL OF MOLECULAR MEDICINE-JMM (2018)

Article Oncology

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

Oukseub Lee, Megan E. Sullivan, Yanfei Xu, Chiara Rogers, Miguel Muzzio, Irene Helenowski, Ali Shidfar, Zexian Zeng, Hari Singhal, Borko Jovanovic, Nora Hansen, Kevin P. Bethke, Peter H. Gann, William Gradishar, J. Julie Kim, Susan E. Clare, Seema A. Khan

CLINICAL CANCER RESEARCH (2020)

Article Endocrinology & Metabolism

Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome

Teerawat Wiwatpanit, Alina R. Murphy, Zhenxiao Lu, Margrit Urbanek, Joanna E. Burdette, Teresa K. Woodruff, J. Julie Kim

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Multidisciplinary Sciences

Generation of Multicellular Human Primary Endometrial Organoids

Alina R. Murphy, Teerawat Wiwatpanit, Zhenxiao Lu, Batzaya Davaadelger, J. Julie Kim

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)

Article Cell & Tissue Engineering

Microphysiological Modeling of the Human Endometrium

Hannes Campo, Alina Murphy, Sule Yildiz, Teresa Woodruff, Irene Cervello, J. Julie Kim

TISSUE ENGINEERING PART A (2020)

Review Obstetrics & Gynecology

Menstruation: science and society

Hilary O. D. Critchley, Elnur Babayev, Serdar E. Bulun, Sandy Clark, Iolanda Garcia-Grau, Peter K. Gregersen, Aoife Kilcoyne, Ji-Yong Julie Kim, Missy Lavender, Erica E. Marsh, Kristen A. Matteson, Jacqueline A. Maybin, Christine N. Metz, Inmaculada Moreno, Kami Silk, Marni Sommer, Carlos Simon, Ridhi Tariyal, Hugh S. Taylor, Gunter P. Wagner, Linda G. Griffith

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Article Obstetrics & Gynecology

Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating

Tia Jackson-Bey, Jose Colina, Brett C. Isenberg, Jonathan Coppeta, Margrit Urbanek, J. Julie Kim, Teresa K. Woodruff, Joanna E. Burdette, Angela Russo

HUMAN REPRODUCTION (2020)

Article Obstetrics & Gynecology

HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma

Yinuo Li, Wenan Qiang, Brannan Brooks Griffin, Tingting Gao, Debabrata Chakravarti, Serdar Bulun, J. Julie Kim, Jian-Jun Wei

FERTILITY AND STERILITY (2020)

Letter Obstetrics & Gynecology

Reply: Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating

Tia Jackson-Bey, Jose Prime Colina, Brett C. Isenberg, Jonathan Coppeta, Margrit Urbanek, J. Julie Kim, Teresa K. Woodruff, Joanna E. Burdette, Angela Russo

HUMAN REPRODUCTION (2021)

Article Oncology

Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes

Oukseub Lee, Maarten C. Bosland, Minhua Wang, Ali Shidfar, Omid Hosseini, Xiaoling Xuei, Priyam Patel, Matthew J. Schipma, Irene Helenowski, J. Julie Kim, Susan E. Clare, Seema A. Khan

Summary: Results show that ulipristal acetate is the most effective among the selective progesterone receptor modulators studied, while mifepristone is ineffective and telapristone acetate is less effective. Ulipristal acetate reduces tumor incidence and delays tumor onset, and also affects gene expression in benign mammary glands.

CANCER LETTERS (2021)

Editorial Material Biology

Endometrium: Preparing for implantation

J. Julie Kim

Summary: A new laboratory model helps to study the role of senescent cells in fostering a uterine environment that can support an embryo.
Review Oncology

Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States

Mary Towner, J. Julie Kim, Melissa A. Simon, Daniela Matei, Dario Roque

Summary: This review explores the survival rate disparities between black and white women in ovarian, uterine, and cervical cancers, and proposes a theoretical framework to explain how racial differences in experience of preventive strategies, implementation of screening efforts, early detection of symptomatic disease, and appropriate treatment contribute to these disparities.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Article Oncology

Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland

Manish Ranjan, Oukseub Lee, Gannon Cottone, Elnaz Mirzaei Mehrabad, Benjamin T. Spike, Zexian Zeng, Shivangi Yadav, Robert Chatterton, J. Julie Kim, Susan E. Clare, Seema A. Khan

Summary: Research in mouse model shows that exposure to progesterone leads to an increase in mammary stem cells and luminal mature cells, while reducing luminal progenitor cells. However, these effects can be reversed by progesterone receptor antagonists.

BREAST CANCER RESEARCH (2021)

Article Oncology

BRCA1 mutation influences progesterone response in human benign mammary organoids

Batzaya Davaadelger, Mi-Ran Choi, Hari Singhal, Susan E. Clare, Seema A. Khan, J. Julie Kim

BREAST CANCER RESEARCH (2019)

Article Endocrinology & Metabolism

The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model

Vania Vidimar, Debabrata Chakravarti, Serdar E. Bulun, Ping Yin, Romana Nowak, Jian-Jun Wei, J. Julie Kim

ENDOCRINOLOGY (2018)

暂无数据